# Primovist Post-marketing Surveillance in Japan

> **NCT01411449** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2030 (actual)

## Conditions studied

- Diagnostic Imaging

## Interventions

- **DRUG:** Gadoxetic Acid Disodium (Primovist, BAY86-4873)

## Key facts

- **NCT ID:** NCT01411449
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-11
- **Primary completion:** 2010-12-14
- **Final completion:** 2015-02-18
- **Target enrollment:** 2030 (ACTUAL)
- **Last updated:** 2017-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01411449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01411449, "Primovist Post-marketing Surveillance in Japan". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01411449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*